Skip to main content

Animations

MJFF Publications

7511 - 7520 of 9117 Results
Title
Year
  • Year
  • 2008
  • 2017
  • 2009
  • 2018
  • 2014
  • 2012
  • 2013
  • 2014
  • 2007
  • 2021
  • Summary Details
    RESTRICTED
    Title: Generation of Stable Transgenic C. elegans Using Microinjection
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3791/833
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/54981
    Citation Count: 9
  • Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
    2009
    Summary Details
    RESTRICTED
    Title: Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3791/1562
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/55848
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2704
    Citation Count: 407
  • Summary Details
    OPEN
    Title: Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-012-6419-4
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Parkinsonism syndrome in heterozygotes for Niemann–Pick C1
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2013.08.033
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528
    Citation Count: 239
  • Summary Details
    OPEN
    Title: Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes
    Journal Name: The Journal of Physiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1113/jphysiol.2007.143172
    Citation Count: 99
  • Summary Details
    OPEN
    Title: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28500
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.